Effect of β-glucans on an ETEC infection in piglets

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 60-66

  Stuyven, E ^a   Cox, E ^a   Vancaeneghem, S ^a   Arnouts, S ^a   Deprez, P ^a   Goddeeris, B M ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Glucans; Immunostimulation; In vivo; Pigs

Indexed keywords

BETA GLUCAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; IMMUNOSTIMULATION; INTESTINE MUCOSA; MYCOSIS; NONHUMAN; SACCHAROMYCES CEREVISIAE; SCLEROTIUM ROLFSII; SWINE;

ANIMAL FEED; ANIMALS; BETA-GLUCANS; DIARRHEA; DIET; DIETARY SUPPLEMENTS; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; IMMUNOGLOBULINS; SWINE; SWINE DISEASES; WEANING;

ATHELIA ROLFSII; ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE; SUIDAE;

EID: 60849122816     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.311     Document Type: Article

References (45)

1. Adachi Y., Okazaki M., Ohno N., and Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1 → 3) β-d-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol. Pharm. Bull. 17 (1994) 1554-1560
2. Bohn J.A., and BeMiller J.N. (1 → 3)-β-glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr. Polym. 28 (1995) 3-14
3. Chang C.F., Su M.S., Chen H.Y., and Liao I.C. Dietary β-1,3-glucan effectively improves immunity and survival of Panaeus monodon challenged with white spotsyndrome virus. Fish Shellfish Immunol. 15 (2003) 297-310
4. Cook J.A., Holbrook T.W., and Parker B.W. Visceral Leischmaniasis in mice: protective effect of glucan. J. Reticuloendothel. Soc. 27 (1980) 567-573
5. Deprez P., Van Den Hende C., Muylle E., and Oyaert W. The influence of the administration of sow's milk on the postweaning excretion of heamolytic Escherischia coli in the pig. Vet. Res. Commun. 10 (1986) 469-478
6. Drandarska I., Kussovski V., Nikolaeva S., and Markova N. Combined immunomodulating effects of BCG and Lentinan after intranasal application in guinea pigs. Int. Immunopharmacol. 5 (2005) 795-803
7. Dritz S.S., Shi J., Kielian T.L., Goodband R.D., Nelssen J.L., Tokach M.D., Chengappa M.M., Smith J.E., and Blecha F. Influence of dietary β-glucan on growth performance, nonspecific immunity and resistance to Streptococcus suis infection in weanling pigs. J. Anim. Sci. 73 (1995) 3341-3350
8. Fleet G.H., and Manners D.G. Isolation and composition of an alkali-soluble glucan from the cell wall of Saccharomyces cerevisiae. J. Gen. Microbiol. 94 (1976) 180-192
9. Hampson D.J. Postweaning Escherichia coli diarrhoea in pigs. In: Gyles C.L. (Ed). Escherichia coli in Domestic Animals and Humans (1994), CAB International, Wallingford, Oxon, UK 171-191
10. Hamuro J., Maeda Y.Y., Arai Y., Fukuoka F., and Chihara G. Significance of the higher structure of the polysaccharides lentinan and pachymaran with regard to their antitumor activity. Chem. Biol. Interact. 3 (1971) 69-71
11. Hashimoto K., Suzuki I., and Yadomae T. Oral administration of SSG, a β-glucan obtained from Sclerotinia sclerotiorum, affects the functions of Peyer's patch cells. Int. J. Immunopharmacol. 13 (1991) 437-442
12. Hetland G., Ohno N., Aaberge I.S., and Lovik M. Protective effect of beta-glucan against systemic streptococcus pneumoniae infection in mice. FEMS Immunol. Med. Microbiol. 27 (2000) 111-116
13. Kokoshis P.L., Williams D.L., Cook J.A., and DiLuzio N.R. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 207 (1978) 1340-1342
14. Lowe E.P., Wei D., Rice P.J., Li C., Kalbfleisch J., Browder I.W., and Williams D.L. Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulate nuclear factor κB activation and interleukin 8 production. Am. Surg. 68 (2002) 508-517
15. Maeda Y.Y., Watanabe S.T., Chihara C., and Rokutanda M. Denaturation and renaturation of a β-1,6:1,3-glucan, lentinan, associated with expression of T-cell-mediated responses. Cancer Res. 48 (1988) 671-675
16. Markevich N.A., Maslennikova I.I., Pokrovskaia E.E., Osipova W., and Isolatova A.V. The mechanism of the formation of heterologous resistance in peroral immunization with a complex anti-influenza preparation. Vestn. Ross. Akad. Med. Nauk. 1 (1996) 51-54
17. Mohagheghpour N., Dawson M., Hobbs P., Judd A., Winant R., Dousman L., Waldeck N., Hokoma L., Tusé D., Kos F., Benike C., and Engleman E. Glucans as immunological adjuvans. Immunobiol. Protein Pept. VIII (1995) 13-22
18. Nagi N., Ohno N., Adachi Y., Aketagawa J., Tanuira H., Shibata Y., Tanaka S., and Yadomae T. Application of limulus test (G pathway) for the detection of different conformers of (1 → 3)-d-glucans. Biol. Pharm. Bull. 16 (1993) 822
19. Newby T.J., Stokes C.R., Evans P.A., and Bourne F.J. The immune response following oral vaccination with E. coli. Curr. Top. Vet. Med. Anim. Sci. 12 (1981) 377-388
20. Ohno N., Asada N., Adachi Y., and Yadomae T. Enhancement of LPS-triggered TNF-α production by (1 → 3)-β-d-glucans in mice. Biol. Pharm. Bull. 18 (1995) 126-133
21. Okazaki M., Adachi Y., Ohno N., and Yadomae T. Structure-activity relationship of (1 → 3)-β-glucans in the induction of cytokine production from macrophage in vitro. Biol. Pharm. Bull. 18 (1995) 1320-1327
22. Okazaki M., Chiba N., Adachi Y., Ohno N., and Yadomae T. Signal transduction pathway on β-glucans-triggered hydrogen peroxide production by murine peritoneal macrophages in vitro. Biol. Pharm. Bull. 19 (1996) 18-23
23. Osek J., Truszozynski M., Tarasuik K., and Pejsak Z. Evaluation of different vaccines to control of pig colibacillosis under large-scale farm conditions. Comp. Immune Microbial. Infect. Dis. 18 (1995) 1-8
24. Pyz E., Marshall A.S.J., Gordon S., and Brown G.D. C-type lectin-like receptors on myeloid cells. Ann. Med. 38 (2006) 242-251
25. Raa J. The use of immunostimulatory substances in fish and shellfish farming. Rev. Fischer. Sci. 4 (1996) 229-288
26. Rasschaert K., Verdonck F., Goddeeris B.M., Duchateau L., and Cox E. Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection. Vet. Microbiol. 123 (2007) 249-253
27. Rice P., Adams J., Ozment-Skelton T., Gonzalez A.J., Goldman M.P., Lockhart B.E., Barker L.A., Breuel K.F., DePonti W.K., Kalbfleisch J.H., Ensley H.E., Brown G.D., Gordon S., and Williams D.L. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J. Pharmacol. Exp. Ther. 314 (2005) 1079-1086
28. Robertsen B., Rørstad G., Engstad R., and Raa J. Enhancement of non-specific disease resistance in Atlantic salmon, Salmo salar L., by a glucan from Saccharomyces cerevisiae cell walls. J. Fish Dis. 13 (1990) 391-400
29. Rutters J.M., and Jones G.W. Protection against enteric disease caused by Escherichia coli-a model for vaccination with a virulence determinant?. Nature 242 (1973) 531-532
30. Sherwood E.R., Williams D.L., Mc Namer R., Jones E., Browder I.W., and Di Luzio N. Enhancement of IL-1 and IL-2 production by soluble glucan. Int. J. Immunopharmacol. 9 (1987) 261-267
31. Snoeck V., Huyghebaert N., Cox E., Vermeire A., Vancaeneghem S., Remon J.P., and Goddeeris B.M. Enteric coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Vet. Immunol. Immunopathol. 96 (2003) 219-227
32. Suzuki I., Hashimoto K., Ohno N., Tanaka H., and Yadomae T. Immunomodulation by orally administered β-glucan in mice. Int. J. Immunopharmacol. 11 (1989) 761-769
33. Suzuki T., Tanaka H., Kinoshita A., Oikawa S., Ohsawa M., and Yadomae T. Effect of orally administered β-glucan on macrophage function in mice. Int. J. Immunopharmacol. 12 (1990) 675-684
34. Van den Broeck W., Cox E., and Goddeeris B.M. Induction of immune responses in pigs following oral administration of purified F4 fimbriae. Vaccine 17 (1999) 2020-2029
35. Van den Broeck W., Cox E., and Goddeeris B.M. Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect. Immun. 67 (1999) 520-526
36. Van den Broeck W., Cox E., and Goddeeris B.M. Receptor-specific binding of purified F4 to isolated villi. Vet. Microbiol. 68 (1999) 255-263
37. Van der Stede Y., Cox E., and Goddeeris B.M. Antigen dose modulates the immunoglobulin isotype responses of pigs against intramuscularly administrated F4-fimbriae. Vet. Immunol. Immunopathol. 88 (2002) 209-216
38. Van der Stede Y., Cox E., Verdonck F., Vancaeneghem S., and Goddeeris B.M. Reduced F4+ E. coli excretion by intramuscular immunisation of suckling piglets is improved by addition of 1alpha, 25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides. Vaccine 21 (2003) 1023-1032
39. Verdonck F., Cox E., Van Gog K., Van der Stede Y., Deprez P., Duchateau L., and Goddeeris B. Different kinetic of antibody responses following infection of newly weaned piglets with a F4 enterotoxigenic E. coli strain or a F18 verotoxigenic E. coli strain. Vaccine 20 (2002) 2993-3004
40. Verdonck F., Cox E., Van der Stede Y., and Goddeeris B.M. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response. Vaccine 22 (2004) 4291-4299
41. Vetvicka V., Terayama K., Mandeville R., Brousseau P., Kournikakis B., and Ostroff G. Orally administered yeast beta-1,3-glucan prophylactically protects against anthrax infection and cancer in mice. J. Am. Nutriceutical Assoc. 5 (2002) 1-5
42. Williams D.L., Cook J., Hoffmann E.O., and Di Luzio N.R. Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23 (1978) 479-490
43. Williams D.L., and DiLuzio N.R. Glucan induced modification of murine viral hepatitis. Science 208 (1980) 67-69
44. Williams D.L., Sherwood E.R., Browder I.W., Mc Namee R.B., Jones E.L., Rakinic J., and Di Luzio N.R. Effect of glucan on neutrophil dynamics and immune functions in E. coli peritonitis. J. Surg. Res. 44 (1988) 54-61
45. Zeković D.B., and Kwiatkowski S. Natural and modified (1 → 3)-beta-d-glucans in health promotion and disease alleviation. Crit. Rev. Biotechnol. 25 (2005) 205-230